Norepinephrine Dosing for Hypotension
Preparation and Administration
- The American Heart Association recommends administration of norepinephrine through a central venous line whenever possible to prevent tissue necrosis from extravasation 1, 2
Titration and Monitoring
- Titrate to achieve a target mean arterial pressure (MAP) of 65-100 mmHg, sufficient to maintain vital organ perfusion, as recommended by the American Heart Association 1, 2
- Continuous hemodynamic monitoring is essential during administration, according to the American Academy of Allergy, Asthma, and Immunology 3
- Monitor for signs of extravasation; if it occurs, infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline into the site to prevent tissue necrosis, as recommended by the American Heart Association 1, 2
Clinical Considerations and Precautions
- Norepinephrine is indicated for severe hypotension (e.g., systolic BP ≤70 mmHg) with low peripheral vascular resistance, according to the American Heart Association 1, 4, 2
- It is relatively contraindicated in hypovolemic patients; always correct volume depletion before or concurrently with norepinephrine administration, as recommended by the American Heart Association 1, 2
- Use cautiously in patients with ischemic heart disease as it may increase myocardial oxygen requirements, according to the American Heart Association 1, 4
- While norepinephrine typically causes renal and mesenteric vasoconstriction, it may actually improve renal blood flow and urine output in septic shock, as noted by the American Heart Association 1, 4
Special Situations
- The European Society of Cardiology recommends a dosage range of 0.2-1.0 μg/kg/min for acute heart failure 5
Potential Adverse Effects
- Increased myocardial oxygen consumption may occur, as noted by the American Heart Association 2
- Tissue necrosis if extravasation occurs, as warned by the American Heart Association 1
- Arrhythmias at higher doses may occur, according to the American Academy of Allergy, Asthma, and Immunology 3
- Excessive vasoconstriction leading to end-organ hypoperfusion may occur, as noted by the European Society of Cardiology 5
Norepinephrine Infusion Protocol for Hypotension
Initial Dosing and Administration
- If blood pressure remains inadequate despite increasing doses, consider adding a second vasopressor agent, as recommended by the American Heart Association, to achieve a target mean arterial pressure (MAP) of 65-100 mmHg 6, 7
Monitoring During Infusion
- Monitor for signs of extravasation; if it occurs, infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline into the site, according to the American College of Cardiology 7
- Assess peripheral perfusion regularly (skin temperature, capillary refill), as suggested by the European Society of Cardiology 8
Weaning Protocol
- Decrease the norepinephrine dose by 25% of the current dose every 30 minutes as tolerated, as recommended by the American Heart Association 7
Special Considerations for Elderly Patients
- Higher doses of norepinephrine (>10 mcg/minute) are associated with increased mortality and should be avoided if possible, according to the American College of Cardiology 7
Norepinephrine Drip Dosage for Hypotension
Dosing Considerations
- For refractory hypotension, consider escalating the dose or adding alternative vasopressors, as suggested by the British Journal of Anaesthesia 9
Norepinephrine Administration and Effects
Indications and Usage
- The European Society of Cardiology recommends norepinephrine as a preferred vasopressor in situations with low blood pressure related to reduced systemic vascular resistance, such as septic shock 10, 11
- Norepinephrine is used in cardiogenic shock when a combination of inotropic agents and fluid challenge fails to restore adequate arterial and organ perfusion, as suggested by the European Heart Journal 10, 12
Dosage and Administration
- The typical dosage range of norepinephrine is 0.2-1.0 μg/kg/min, according to the European Heart Journal 10, 12
Contraindications and Precautions
- In cardiogenic shock, norepinephrine should be used with caution and only transiently due to the risk of increasing afterload and further decreasing end-organ blood flow, as noted by the European Heart Journal 10, 12
Adverse Reactions and Side Effects
- Norepinephrine may reduce end-organ perfusion, particularly renal and mesenteric blood flow, as reported by the European Heart Journal 10, 12
Interactions
- Concurrent use of norepinephrine with phosphodiesterase inhibitors may cause severe hypotension, according to the European Heart Journal 10, 13
- Norepinephrine may have additive effects when combined with other vasopressors, and is often combined with dobutamine to improve hemodynamics in cardiogenic shock, as suggested by the European Heart Journal 10, 12
Hemodynamic and Multi-system Effects
- Norepinephrine increases systemic vascular resistance and mean arterial pressure, with less increase in heart rate compared to epinephrine, as reported by the European Heart Journal 10, 12
- Norepinephrine may increase cardiac afterload, potentially reducing cardiac output in patients with heart failure, according to the European Heart Journal 10, 12
- Norepinephrine may reduce splanchnic blood flow, as noted by the European Heart Journal 10, 12
Norepinephrine Dosing for Hypotension in Adults
Vasopressor Selection and Administration
- The Surviving Sepsis Campaign strongly recommends norepinephrine as the first-choice vasopressor for septic shock over alternatives like dopamine or phenylephrine, based on moderate quality evidence showing superior outcomes with norepinephrine 14, 15
- Dopamine should only be used in highly selected patients with low risk of tachyarrhythmias and absolute or relative bradycardia, as recommended by the Surviving Sepsis Campaign 14, 15
Monitoring and Titration
- Place an arterial catheter as soon as practical in all patients requiring vasopressors, as recommended by the Intensive Care Medicine and Critical Care Medicine guidelines 14, 15